Conformis Inc Revenue Growth Rates (CFMS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Conformis inc   (CFMS)
 

CFMS's Revenue Growth by Quarter and Year

Conformis Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CFMS Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter December -
3rd Quarter September -
2nd Quarter June 13.02
1st Quarter March 12.84
FY 25.86

CFMSs Annual Revenue
Conformis Inc 's Revenue in the fiscal year 2022 $ 62.05 millions
Conformis Inc 's Revenue in the fiscal year 2021 $ 99.86 millions
Conformis Inc 's Revenue in the fiscal year 2020 $ 68.76 millions
Conformis Inc 's Revenue in the fiscal year 2019 $ 77.43 millions
Conformis Inc 's Revenue in the fiscal year 2018 $ 89.79 millions




CFMS Revenue second quarter 2023 Y/Y Growth Comment
Conformis Inc reported fall in Revenue in the second quarter 2023 by -14.88% to $ 13.02 millions, from the same quarter in 2022.
The decline in the second quarter 2023 Conformis Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 2.64%.

Looking into second quarter 2023 results within Medical Equipment & Supplies industry 156 other companies have achieved higher Revenue growth. While Conformis Inc ' s Revenue decrease of -14.88% ranks overall at the positon no. 3210 in the second quarter 2023.


CFMS Revenue ( Y/Y Growth %) 2023
 2022 2021 2020
4th Quarter December - 12.97 % -7.66 % -16.04 %
3rd Quarter September - -3.3 % -11.6 % -6.82 %
2nd Quarter June -14.88 % -72.85 % 189.42 % -0.61 %
1st Quarter March -17.43 % 12.36 % -16.02 % -20.16 %
FY   - -37.86 % 45.21 % -

Financial Statements
Conformis Inc 's second quarter 2023 Revenue $ 13.02 millions CFMS's Income Statement
Conformis Inc 's second quarter 2022 Revenue $ 15.30 millions Quarterly CFMS's Income Statement


CFMS Revenue (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
4th Quarter December - 26.42 % 8.21 % 3.6 %
3rd Quarter September - -9.93 % -74.71 % -17.21 %
2nd Quarter June 1.43 % -1.61 % 307.15 % 18.14 %
1st Quarter March -26.29 % 0.84 % -17.13 % -17.14 %
FY (Year on Year)   - -37.86 % 45.21 % -


Back to CFMS Growth rate Comparisons >> Back to CFMS Growth rate Comparisons >>


Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #157
Healthcare Sector #501
Overall #3210

Revenue Y/Y Growth Statistics
High Average Low
189.44 % 2.64 % -72.86 %
(Jun 30 2021)   (Jun 30 2022)
Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #157
Healthcare Sector #501
Overall #3210
Revenue Y/Y Growth Statistics
High Average Low
189.44 % 2.64 % -72.86 %
(Jun 30 2021)   (Jun 30 2022)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Conformis Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
307.29 % 8.05 % -74.71 %
(Jun 30 2021)  


CFMS's II. Quarter Q/Q Revenue Comment
Conformis inc achieved in the II. Quarter 2023 below company average Revenue growth of 1.43% quarter on quarter, to $ 13.02 millions.

II. Quarter 2023 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -1.61% in the II. Quarter a year ago.

Within Medical Equipment & Supplies industry 138 other companies have achieved higher Revenue quarter on quarter growth. While Conformis Inc 's Revenue growth quarter on quarter, overall rank is 2429.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #139
Healthcare Sector #441
Overall #2429
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #139
Healthcare Sector #441
Overall #2429
Revenue Q/Q Growth Statistics
High Average Low
307.29 % 8.05 % -74.71 %
(Jun 30 2021)  


CFMS's II. Quarter Q/Q Revenue Comment
Conformis inc achieved in the II. Quarter 2023 below company average Revenue growth of 1.43% quarter on quarter, to $ 13.02 millions.

II. Quarter 2023 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -1.61% in the II. Quarter a year ago.

Within Medical Equipment & Supplies industry 138 other companies have achieved higher Revenue quarter on quarter growth. While Conformis Inc 's Revenue growth quarter on quarter, overall rank is 2429.


Conformis Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2023)		 12 Months Ending
(Mar 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Sep 30 2022)		 12 Months Ending
(Jun 30 2022)
Cumulative Revenue 12 Months Ending $ 57.06 $ 59.34 $ 62.05 $ 60.05 $ 60.52
Y / Y Revenue Growth (TTM) -5.72 % -41.58 % -37.86 % -40.62 % -41.24 %
Year on Year Revenue Growth Overall Ranking # 3583 # 429 # 323 # 2429 # 3397
Seqeuential Revenue Change (TTM) -3.83 % -4.37 % 3.32 % -0.77 % -40.42 %
Seq. Revenue Growth (TTM) Overall Ranking # 3584 # 2269 # 2568 # 2174 # 3883


Cumulative Revenue growth Comment
Conformis Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2023. If the fiscal year would end in Jun 30 2023, Conformis Inc 's annual Revenue drop would be -5.72% year on year to $57 millions.

In the Healthcare sector 520 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 429 to 3583.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 163
Healthcare Sector # 521
Overall # 3583

Revenue TTM Y/Y Growth Statistics
High Average Low
53.62 %
 -1.14 %
-41.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 163
Sector # 519
S&P 500 # 3584
Cumulative Revenue growth Comment
Conformis Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2023. If the fiscal year would end in Jun 30 2023, Conformis Inc 's annual Revenue drop would be -5.72% year on year to $57 millions.

In the Healthcare sector 520 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 429 to 3583.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 163
Healthcare Sector # 521
Overall # 3583

Revenue TTM Y/Y Growth Statistics
High Average Low
53.62 %
-1.14 %
-41.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 163
Sector # 519
S&P 500 # 3584




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CFMS's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2023
Fortrea Holdings Inc -0.01%$ -0.013 millions
Aquestive Therapeutics Inc -0.18%$ -0.181 millions
Phibro Animal Health Corporation-0.34%$ -0.340 millions
Procyon Corporation-0.59%$ -0.589 millions
Amedisys Inc-0.88%$ -0.882 millions
Baxter International Inc -1.04%$ -1.041 millions
Healthcare Services Group Inc -1.39%$ -1.395 millions
Bio rad Laboratories Inc -1.54%$ -1.536 millions
Harvard Bioscience Inc -1.83%$ -1.832 millions
Embecta Corp -1.92%$ -1.924 millions
Procaps Group S a -2.10%$ -2.102 millions
Enhabit Inc -2.13%$ -2.127 millions
Icu Medical Inc-2.26%$ -2.260 millions
Tandem Diabetes Care Inc -2.26%$ -2.261 millions
West Pharmaceutical Services Inc -2.27%$ -2.269 millions
Coherus Oncology inc -2.39%$ -2.386 millions
Hookipa Pharma inc -2.44%$ -2.440 millions
Biolife Solutions Inc -2.53%$ -2.529 millions
Enanta Pharmaceuticals Inc-3.01%$ -3.014 millions
Nrc Health-3.03%$ -3.033 millions
Intellia Therapeutics Inc -3.11%$ -3.108 millions
Organogenesis Holdings Inc -3.36%$ -3.365 millions
Omniab Inc -3.51%$ -3.514 millions
Marker Therapeutics inc -3.52%$ -3.523 millions
Akumin Inc -3.79%$ -3.793 millions
Endo International Plc-3.91%$ -3.912 millions
Integra Lifesciences Holdings Corp-4.16%$ -4.160 millions
Vireo Growth Inc.-4.24%$ -4.237 millions
Sonendo Inc -4.26%$ -4.257 millions
Avinger Inc -4.27%$ -4.268 millions


About Conformis Inc Revenue Growth Rates (CFMS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Conformis Inc (CIK 1305773).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001305773-23-000039
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Conformis Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.